does tirzepatide cause birth defects mothertobaby fact sheet pregnancy Have you ever heard the word “teratogen” or “teratology” and wondered Understanding GLP-1 Medications and Pregnancy

however, this contradicts established trial data favoring SGLT2 inhibitors for heart failure and should be interpreted cautiously due to possible residual confounding

Yerba mate contains compounds that may modestly influence metabolic pathways, but research shows prescription GLP-1 medications produce far greater effects on appetite suppression and weight loss than herbal beverages alone

Were proud to power their awareness through our radio shows Connect with us today ...

Adults with overweight or obesity taking the once-weekly GIP/GLP-1 receptor agonist tirzepatide achieved a mean weight loss of at least 16% at 72 weeks, according to topline results from the SURMOUNT-1 clinical trial

Discover clinical reasons why Mounjaro effectiveness slows, practical strategies to overcome stalling, and how PlexusDx personalized therapy can restart your results